Accelerating study start-up is a top priority among leading life sciences companies. With this shift underway, an increasing number of organizations are selecting Vault Study Startup from Veeva Systems to improve clinical trial efficiency and speed time to site activation. Seven of the top 20 largest global pharmaceutical companies are adopting Vault Study Startup to bring together start-up activities and processes in a single, easy-to-use modern cloud application. Veeva Vault Study Startup is an advanced application that eliminates manual processes to speed cycle times and trial execution. Sponsors can find the right site faster by automating and streamlining site identification, feasibility, and selection. Companies can also prioritize and assign tasks such as site contracting and budgeting throughout their study portfolio – an area that accounts for most of the cycle time during study start-up.